よきにはからえ 尼百会いち
- カテゴリ：日記
- 2024/03/14 09:36:06
marzo 14 giovedi
Doctors here in Japan have started prescribing a new weight-loss drug to patients who suffer from obesity.
But there are concerns people could use it for cosmetic purposes, making it harder for those who need it to get access.
This woman regularly meets a doctor to treat her obesity.
(Ono Hiraku / Associate Professor, Chiba University Hospital)
“A new medicine called Wegovy went on sale today. So let's give it a try.”
The drug was developed by Danish pharmaceutical firm Novo Nordisk.
Its active ingredient, semaglutide, mimics the effects of an appetite-regulating hormone.
Japan's public health insurance system covers the use of Wegovy for patients diagnosed with obesity, as well as high blood pressure and other symptoms.
But a growing number of people are turning to diabetes drugs containing semaglutide for cosmetic purposes.
Experts say using the medicine without doctor supervision can be dangerous.
